K042094

Substantially Equivalent

R&D CBC-XE HEMATOLOGY CONTROL

Applicant: R&D Systems, Inc.
Product code: JPK
Advisory panel: Hematology
Date received: 2004-08-03
Decision date: 2004-09-01
Decision: Substantially Equivalent
Clearance type: Special
Location: Minneapolis, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.